Are urine mycotoxin tests accurate?

Urine mycotoxin tests have not been validated for clinical use according to the CDC (2014). While labs like RealTime Laboratories claim analytical accuracy under CLIA and CAP standards, analytical accuracy (can the test detect the compound?) is different from clinical validity (does a positive result mean someone is ill from mold?). Critically, multiple control studies found 80-100% positive rates in healthy people with no mold illness.

What did the CDC say about urine mycotoxin tests?

In 2014, CDC/NIOSH published a report warning that urine mycotoxin tests have not been validated for clinical use in diagnosing mold-related illness. The CDC noted that using unvalidated tests 'can lead to misinformation and fear, incorrect diagnoses, unnecessary medical interventions, and inappropriate environmental evaluations.'

What is the false positive rate for urine mycotoxin tests?

Control studies across six continents found mycotoxin positivity rates of 80-100% in healthy populations with no mold illness: 87% in German adults, 90% in UK elderly (for DON/deoxynivalenol), and 99% in some Nigerian samples (for aflatoxin). This suggests exposure to mycotoxins through food (not just building mold) produces widespread positive results that cannot be attributed to mold illness.

Is RealTime Labs mycotoxin testing reliable?

RealTime Laboratories operates a CLIA-certified and CAP-accredited laboratory, which verifies their analytical methodology. However, clinical critics note that analytical validity (the test can detect mycotoxins) does not establish clinical validity (a positive result indicates mold-illness). The test cannot distinguish between mycotoxin exposure from food sources vs water-damaged building mold.

What should I do instead of a urine mycotoxin test?

The most actionable first step is a professional environmental inspection of your home and workplace. If mold or water damage is found and remediated, this addresses the source directly. An ACAC-certified or CIH inspector can assess your environment. Call Mold Remediation Hotline at (332) 220-0303 for guidance on professional testing and remediation.

Mycotoxin Testing Research • 2026

Urine Mycotoxin Test Accuracy: What the CDC & Research Actually Show

80–100% positive rate in healthy populations with no mold illness — across six continents — making "positive" results alone clinically meaningless. Source: Control studies reviewed by CDC (2014).

You paid $300–600 for a urine mycotoxin test. It came back positive. What does that actually mean? Here is what the CDC, toxicologists, and clinical researchers say — and what it doesn't tell you.

✆ Get Real Environmental Testing (332) 220-0303 See Lab Comparison

Urine Mycotoxin Test Clinical Accuracy Research

The Critical Finding

What the Evidence Shows About These Tests

80–100%healthy people test "positive" — control studies from 6 continents

German adults: 87% positive. UK elderly: 90% positive for DON. This makes a positive result impossible to interpret without clinical context.

0FDA-approved urine mycotoxin tests for clinical diagnosis of illness

These tests are not approved by the FDA for accuracy or for clinical use in diagnosing mold-related illness. — CDC/NIOSH 2014

2014Year CDC warned against using these tests for clinical decisions

More than 12 years later, the CDC's position remains unchanged: unvalidated tests can lead to incorrect diagnoses and unnecessary interventions.

CLIA ≠ ClinicalLab accreditation ≠ clinical validity

RealTime Labs is CLIA-certified and CAP-accredited — this means the lab accurately detects the compound. It does NOT mean a positive result indicates mold illness.

Lab-by-Lab Comparison

GPL, RealTime Labs & GFMI: What Each Offers

Three commercial labs dominate the urine mycotoxin testing market for mold illness. Here is what each offers — and what remains unvalidated:

Lab	Accreditation	Mycotoxins Tested	Peer-Reviewed Clinical Validation?	Key Limitation
RealTime Laboratories	CLIA, CAP	Trichothecenes, Ochratoxin A, Aflatoxins, Gliotoxin	No	Analytical accuracy only — no clinical validation study distinguishing ill from healthy patients published
Great Plains Laboratory (GPL)	CLIA	Ochratoxin A, Aflatoxins, Trichothecenes	No	Uses ELISA method — same method type CDC cited for producing 80-100% positives in healthy controls
GFMI (Great Plains alt. labs)	Varies	Similar panel to above	No	No published peer-reviewed validation of clinical use for mold illness diagnosis

Sources: CDC MMWR 2014; RealTime Laboratories FAQ; MoldCo.com analysis; Gary Rosen urine testing analysis (expert-on-mold.com, 2023).

Urine Mycotoxin Test Lab Comparison Research

The Core Problem: Analytical vs Clinical Validity

CLIA and CAP accreditation means a lab can accurately measure whether a compound is present. It does NOT mean the presence of that compound indicates mold illness. Mycotoxins from food sources (contaminated grain, nuts, dried fruit, coffee, wine) are detectable in virtually everyone's urine — because mycotoxins are widespread in the food supply, not just in water-damaged buildings.

As the CDC noted: "Mycotoxin levels that predict disease have not been established." Without knowing what level of mycotoxin in urine distinguishes a sick person from a healthy food consumer, the test cannot be interpreted clinically.

What the Research Shows

The Control Study Problem

The most damaging finding for urine mycotoxin testing clinical validity comes from control group studies — the same research design used to evaluate any diagnostic test:

Healthy Populations Test Overwhelmingly Positive

A review of 21 control studies across six continents found mycotoxin positivity rates of 80–100% in healthy people with no history of mold illness:

German adults with no mold exposure history: 87% positive
UK elderly (for deoxynivalenol/DON): 90% positive
Some international samples: up to 99% positive for certain mycotoxins

This finding — that healthy people test positive at nearly the same rate as people claiming mold illness — is what makes clinical interpretation impossible without additional context. The mycotoxins found in urine largely reflect diet, not building mold exposure.

What the Brewer 2013 Study Actually Shows

The most-cited study supporting urine mycotoxin testing (Brewer et al. 2013) found that 93% of 112 CFS patients had detectable mycotoxins in urine. However, the study's control group was specifically chosen to have no history of mold exposure — a selection bias that guaranteed the test would appear to distinguish groups. When compared to a randomly selected healthy population (where 80-100% test positive), the results lose their diagnostic value. See our companion guide on mold exposure and ME/CFS statistics.

What to Do Instead

Evidence-Based Steps for Suspected Mold Illness

If you suspect mold is causing your symptoms, the evidence-based sequence focuses on the environment first:

Step 1: Professional Environmental Inspection

Have your home and workplace inspected by an ACAC-certified mold inspector or Certified Industrial Hygienist (CIH). Environmental testing — air samples and surface samples — is far better validated than urine testing for identifying whether you have a mold problem. See our guide on indoor mold spore count guidelines to understand what results mean.

Step 2: Environmental Remediation Before Medical Treatment

If mold is found, professional remediation per IICRC S520-2024 standards removes the exposure source. Many patients whose symptoms were attributed to mold illness improve significantly after remediating the building — regardless of urine mycotoxin test results.

Step 3: Discuss Testing Caveats with Your Doctor

If your physician orders a urine mycotoxin test, discuss the CDC's clinical validity concerns. Ask specifically: "What would a positive result change about my treatment plan?" and "How do you interpret results given that 80-100% of healthy people test positive?" An answer to those questions helps you assess whether the test adds value in your specific case.

Frequently Asked Questions

Urine Mycotoxin Tests: Your Questions Answered

Are urine mycotoxin tests FDA-approved?

No. Urine mycotoxin tests are not approved by the FDA for accuracy or for clinical use in diagnosing mold-related illness. Labs may hold CLIA certification (for general laboratory methodology), but this is not an FDA approval of the test for clinical diagnosis of mycotoxicosis.

What did the CDC say about urine mycotoxin testing in 2014?

The CDC/NIOSH 2014 report warned that using unvalidated urine mycotoxin tests can lead to: misinformation and fear in workplaces, incorrect diagnoses, unnecessary and potentially harmful medical interventions, and unnecessary or inappropriate environmental evaluations. The CDC specifically noted these tests have not been validated for clinical use.

My urine mycotoxin test was positive — does that mean I have mold illness?

Not necessarily. Because 80-100% of healthy people with no mold illness also test positive (due to dietary mycotoxin exposure from food), a positive result alone cannot confirm mold illness. Clinical interpretation requires considering your symptom pattern, exposure history (water-damaged building), and environmental testing of your home. The most valuable next step is a professional mold inspection.

Is there a validated test for mold illness?

No single test is clinically validated for diagnosing mycotoxicosis. Clinical assessment combines symptoms, exposure history, response to environmental change, and general inflammatory markers. Environmental testing of your home with air and surface samples by a certified inspector is the most actionable diagnostic approach.

Should I spend $400 on a urine mycotoxin test?

Most mold health experts and the CDC would suggest a professional mold inspection of your home is a more valuable first step. An inspection directly identifies whether you have a mold exposure source, which is actionable — you can remediate it. A positive urine test without an identified environmental source leaves you with a result you cannot act on. Call (332) 220-0303 to arrange a professional environmental inspection.

Related Research

More Evidence-Based Mold Guides

Sources

Citations & References

CDC MMWR 2014 — Notes from the Field: Use of Unvalidated Urine Mycotoxin Tests: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a7.htm
PMC full text of CDC 2014 report: https://pmc.ncbi.nlm.nih.gov/articles/PMC4584707/
MoldCo.com — Urine Mycotoxin Test Accuracy analysis: https://www.moldco.com/blog/urine-mycotoxin-test-accuracy-what-do-they-really-show
RealTime Laboratories FAQ: https://realtimelab.com/frequently-asked-questions/
Gary Rosen (Expert on Mold) — Mycotoxin Urine Testing analysis: https://expertonmold.com/wp-content/uploads/2023/08/Mold_Homeowner_Mycotoxins_Testing_Mold-Toxins-in-Urine_Gary-Rosen.pdf
Brewer et al. (2013) — Detection of Mycotoxins in Patients with CFS: https://pmc.ncbi.nlm.nih.gov/articles/PMC3705282/